Previous 10 | Next 10 |
Horizon Therapeutics plc (NASDAQ: HZNP): FORM 8.1(a) & (b) (Opening Position Disclosure) IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE UNDER RULE 8.1(a) AND (b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY AN OFFEROR OR AN OFFEREE 1. KE...
Summary Amgen has become the winner in the Horizon Therapeutics sale process. The deal comes at a full price, offset by synergy estimates and pipeline additions. This is to like, yet I am turning more cautious on the winner of this deal here. Amgen ( AMGN ) has bec...
Amgen (NASDAQ: AMGN) is set to acquire Horizon Therapeutics (NASDAQ: HZNP) in a deal worth approximately USD26 Billion, according to sources familiar with the matter. Horizon shares rose 15% before the opening bell on Monday. The drugmaker is pa...
Summary Amgen is acquiring Horizon Therapeutics for $27.8 billion. The deal immediately adds $3.7 billion in annual revenue. The pipeline should be worth it, with the usual risks. Amgen ( AMGN ) announced today that it will acquire Horizon Therapeutics for $27.8 billio...
Summary Amgen Inc. will acquire Horizon Therapeutics Public Limited Company for $116.50 per share in an all-cash transaction. This is a suboptimal exit for Horizon shareholders, but we should acknowledge the difficult market conditions. Amgen is getting a bargain with multiple growt...
The Dow Jones Industrial Average jumped Monday, clawing back some of the steep losses from the previous week, as traders looked ahead to a highly anticipated Federal Reserve meeting and new inflation data. The 30-stock index hiked 248.11 points to 33,665.15 The S&P 500 gathered 19.82 ...
Horizon Therapeutics Plc ( NASDAQ: HZNP ) is up nearly 15% on Monday after Amgen Inc ( NASDAQ: AMGN ) revealed plans of buying the biopharmaceutical company for $27.8 billion. What it means for Horizon shareholders It’s an all-cash deal that values each share of the Illinoi...
Shares of Horizon Therapeutics (NASDAQ: HZNP) were soaring 14.8% higher as of 10:51 a.m. ET on Monday. The nice gain came after the company announced that Amgen (NASDAQ: AMGN) plans to acquire Horizon in a deal that values the smaller drugmaker at $27.8 billion. This news wasn...
The stock market has gotten locked in a holding pattern lately, and many investors anticipated that would likely continue on Monday. With the Federal Open Market Committee scheduled to meet on Tuesday and Wednesday to discuss monetary policy and a potential interest rate increase, market particip...
U.S. stock futures were fractionally higher early Monday ahead of a week with several anticipated events in the ongoing fight against inflation. Futures for the Dow Jones Industrials took on 54 points, or 0.2%, early Monday to 33,795. Futures for the S&P 500 gained 10.25 points, or 0....
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...